US Judiciary Committee advances four bills to curb antitrust pharma practices

03-08-2021

Alex Baldwin

US Judiciary Committee advances four bills to curb antitrust pharma practices

RiverNorthPhotography / iStockphoto.com

The US Senate Judiciary Committee has unanimously voted to pass four bills that aim to crack down on anti-competitive practices in the pharmaceutical industry.


US Senate Judiciary, FTC, FDA, Chuck Grassley, antitrust, generics, biosimilars

LSIPR